Modified transapical-transcatheter aortic valve implantation.
end-stage panarteriopathy
modified
novelty
transapical-transcatheter aortic valve implantation
Journal
Journal of clinical and translational research
ISSN: 2424-810X
Titre abrégé: J Clin Transl Res
Pays: Singapore
ID NLM: 101667205
Informations de publication
Date de publication:
29 Aug 2022
29 Aug 2022
Historique:
received:
29
05
2022
revised:
11
06
2022
accepted:
07
07
2022
entrez:
22
8
2022
pubmed:
23
8
2022
medline:
23
8
2022
Statut:
epublish
Résumé
Some transcatheter aortic valve implantation (TAVI) candidates present with ubiquitary arterial disease with massive calcification burden and stenoses in the whole arterial tree and cannot undergo any transvascular TAVI-approach. Moreover, a history of previous coronary surgery including LIMA-LITA A high-grade aortic stenosis is a serious disease. Untreated patients exhibit poor survival. Only surgery or TAVI is valid therapy concept for treatment. However, some patients can undergo neither surgery nor TAVI, because of an extensive surgical risk or inoperability, whereas at the same time, no arterial approaches are available due to extensive, end-stage panarteriopathy. For these high-specific patients, our modified, artery-no-touch-TA-TAVI is an appropriate method and can be safely used.
Sections du résumé
Background and Aim
UNASSIGNED
Some transcatheter aortic valve implantation (TAVI) candidates present with ubiquitary arterial disease with massive calcification burden and stenoses in the whole arterial tree and cannot undergo any transvascular TAVI-approach. Moreover, a history of previous coronary surgery including LIMA-LITA
Relevance for Patients
UNASSIGNED
A high-grade aortic stenosis is a serious disease. Untreated patients exhibit poor survival. Only surgery or TAVI is valid therapy concept for treatment. However, some patients can undergo neither surgery nor TAVI, because of an extensive surgical risk or inoperability, whereas at the same time, no arterial approaches are available due to extensive, end-stage panarteriopathy. For these high-specific patients, our modified, artery-no-touch-TA-TAVI is an appropriate method and can be safely used.
Identifiants
pubmed: 35991081
pii: jctres.08.202204.006
pmc: PMC9389571
Types de publication
Journal Article
Langues
eng
Pagination
299-301Informations de copyright
Copyright: © 2022 Author(s).
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Card Surg. 2022 Jun;37(6):1635-1641
pubmed: 35289959
EuroIntervention. 2020 Nov 20;16(10):842-849
pubmed: 32310129
Ann Thorac Surg. 2021 Dec;112(6):1877-1885
pubmed: 33647251
JACC Cardiovasc Interv. 2019 Apr 8;12(7):662-669
pubmed: 30947940
Ann Thorac Surg. 2020 Dec;110(6):1892-1897
pubmed: 32712098
Ann Thorac Surg. 2009 Jan;87(1):276-83
pubmed: 19101311
Eur J Cardiothorac Surg. 2021 Jun 14;59(6):1174-1181
pubmed: 33709139